Suven Pharmaceuticals Faces Volatility Amidst Mixed Performance Metrics and Sector Underperformance

Suven Pharmaceuticals has experienced a notable decline of 3.0% on March 25, 2025, continuing a downward trend over the past two days, resulting in a total drop of 5.57%. Despite opening the day with a gain of 3.3%, the stock reached an intraday high of Rs 1209.2 before falling to a low of Rs 1135.15, reflecting significant volatility with an intraday fluctuation of 5.17%.
In terms of performance metrics, Suven Pharmaceuticals has underperformed compared to its sector, lagging by 1.81%. Over the past month, the stock has decreased by 5.71%, contrasting with the Sensex, which has gained 4.48% during the same period. However, on a longer-term basis, Suven Pharmaceuticals has shown resilience, with a remarkable 75.17% increase over the past year and an impressive 891.15% rise over the last five years.

Currently, the stock's moving averages indicate it is above the 50-day and 200-day averages but below the 5-day, 20-day, and 100-day averages, suggesting mixed short-term performance relative to longer-term trends.